Concepedia

Julia M. Ayala

JM

23

Publications

3.9K

Citations

19

H-Index

1990

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Icahn School of Medicine at Mount Sinai

Julia M. Ayala is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1990–2009

23

Publications

23

A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes

Nancy A. Thornberry, Herbert G. Bull, Jimmy Calaycay et al. · Nature · 1992 · 2.6K citations

, , +6

Activation of the Native 45-kDa Precursor Form of Interleukin-1-converting Enzyme

Ting-Ting Yamin, Julia M. Ayala, Douglas K. Miller · Journal of Biological Chemistry · 1996 · 195 citations · Full text

Leukotriene B<sub>4</sub>Strongly Increases Monocyte Chemoattractant Protein-1 in Human Monocytes

Li Huang, Annie Zhao, Frederick Wong et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2004 · 140 citations

VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis.

Irwin Singer, D W Kawka, E K Bayne et al. · Journal of Clinical Investigation · 1995 · 124 citations · Full text

, , +19

IL-1 <i>beta</i> -converting enzyme is present in monocytic cells as an inactive 45-kDa precursor.

Julia M. Ayala, Ting-Ting Yamin, Linda A. Egger et al. · The Journal of Immunology · 1994 · 114 citations

Rows per page

1–5 of 23